BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Singapore
BEGIN:STANDARD
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
TZNAME:+08
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260403T140829
CREATED:20240227T171412Z
LAST-MODIFIED:20240731T191635Z
UID:1817-1727136000-1727222399@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2024
DESCRIPTION:Deal and investment activity remains critical to the success of life sciences and healthcare innovation. \nRSVP Here \n \n\n\n\n\n\n\n\nSidley once again brings together senior pharma\, biotech\, healthcare\, private equity\, and venture capital executives to share their perspectives on critical issues\, trends\, and opportunities. \nJoin Sidley and industry leaders from across the globe\, including from AstraZeneca\, BioCentury\, Compass Pathways\, Financial Times\, Flagship Pioneering\, IQVIA\, J.P. Morgan\, LetterOne Health\, Mestag Therapeutics\, Morgan Stanley\, Novartis\, Onex\, Permira\, Perspectum\, Rothschild & Co.\, Sofinnova Partners\, Syncona\, SV Health Investors\, and Teva for this in-person\, all-day event. Virtual attendance is available to those outside the UK. \nView the agenda here.\nView confirmed speakers here. \nPanels will include: \n\nPrivate Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?\n\nArtificial Intelligence – To what extent\, and where\, does AI represent an investment opportunity across Healthcare and Life Sciences?\n\nFireside Chat – “A Life in Pharma and Pivoting to Innovation”- A conversation with Richard Francis\, President and CEO\, Teva.\n\nA View From the Banks – Opinions\, insights\, and predictions on the market from a group of leading global healthcare dealmakers.\n\nPharma Business Development – Senior BD and biotech figures debate the M&A\, licensing\, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention?\n\nVenture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nFor more information or questions\, please contact lnevents@sidley.com. \nSIDLEY HEALTHCARE INVESTMENT CONFERENCE 2023 HIGHLIGHTS \n\nView the 2023 agenda\nSidley Healthcare Investment Conference 2023 Highlights Video\nA Life Well Invented: A Discussion Between Moderna Co-Founder and Chairman Noubar Afeyan and Sidley’s Robert Darwin
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2024/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20241022T173000
DTEND;TZID=Europe/Zurich:20241022T210000
DTSTAMP:20260403T140829
CREATED:20240828T152816Z
LAST-MODIFIED:20241010T154919Z
UID:2005-1729618200-1729630800@goodlifesci.sidley.com
SUMMARY:Combination Therapies – EU Regulatory and Competition Law Headwinds and Strategies
DESCRIPTION:Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges\, and potential strategies for EU regulatory and competition law compliance for combination therapies. \n \n\n\nRSVP here. \n\n\nSpeakers are: \n\nDr. Sandra Zaugg Kunz\, Head Regulatory Assessment Deputy Head of Medicinal Product Authorisation and Vigilance\, Swissmedic\nElisabeth Leimbacher\, Global Legal Lead\, Marketing and Commercial Excellence\, Takeda\nCeline Fang\, Senior Antitrust Counsel\, Novartis\n\nThe discussion will be moderated by Josefine Sommer and Anne Robert\, Partner\, Sidley. \nAGENDA \n5:30 p.m. – Arrival and registration\n6:00 p.m. – Panel discussion and Q&A\n7:30 p.m. – Networking and apéro riche \nFor more information\, please contact gvaevents@sidley.com.\nClick here to join the Women’s Life Sciences Network LinkedIn Group.\nFor more information about previous editions\, please click here.
URL:https://goodlifesci.sidley.com/event/combination-therapies-eu-regulatory-and-competition-law-headwinds-and-strategies/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20241114T140000
DTEND;TZID=Europe/Zurich:20241114T183000
DTSTAMP:20260403T140829
CREATED:20240923T150106Z
LAST-MODIFIED:20240923T150308Z
UID:2037-1731592800-1731609000@goodlifesci.sidley.com
SUMMARY:Good Manufacturing Practice 2024Swiss/FDA Mutual Recognition Agreement – State of Play
DESCRIPTION:Join us in Basel\, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to streamline regulatory processes and enhance cooperation between the two countries by recognizing each other’s GMP inspections\, thereby reducing the need for duplicative inspections. \n \nRSVP here. \nWe will discuss early experiences with the new framework — both positive outcomes and challenges — highlighting valuable lessons learned and exploring potential for future developments. \nTopics will include: \n\nFDA/Swiss Mutual Recognition Agreement\nAI and Good Manufacturing Practice\nEU’s New Revised Annex 1\n\nFeatured speakers: \n\nChristian Schärer\, Head of Inspectorate\, Swissmedic\, (keynote speaker)\nOliver Schläfli\, Senior Vice President Global Quality\, Lonza\nJay Jariwala\, Senior Director Regulatory Compliance\, Sidley\nJames Johnson\, Partner\, Sidley\nEva von Mühlenen\, Senior Advisor\, Sidley\n\nWHO SHOULD ATTEND? \nExecutives\, in-house counsel\, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland. \nFor more information or questions\, please contact gvaevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/good-manufacturing-practice-2024swiss-fda-mutual-recognition-agreement-state-of-play/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20250305T130000
DTEND;TZID=America/Los_Angeles:20250305T163000
DTSTAMP:20260403T140829
CREATED:20250124T223249Z
LAST-MODIFIED:20250228T223755Z
UID:2155-1741179600-1741192200@goodlifesci.sidley.com
SUMMARY:Regulatory Know-How for Growth-Stage Life Sciences Innovators
DESCRIPTION:Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues\, and how to tackle them. \n \nIf have questions or are interested in attending\, please contact laevents@sidley.com. \nSessions will focus on: \n\nAll phases of clinical research and development\nPress releases and disclosures\nRegulatory wisdom from experienced emerging growth General Counsels\n\nConnect with industry peers and investors during networking breaks and a post-program cocktail hour. \nThis program is designed for legal professionals and executives to provide a foundation in FDA\, healthcare\, and securities issues arising in development stage companies. \nFeatured Speakers \n\nHimani Bhalla\, Senior Managing Director\, Chief Investment Officer\, and Co-Founder\, Symbiotic Capital\nGreg Bowman\, Senior Director\, Leasing\, Breakthrough Properties\nMichael Brown\, Executive Vice President and Chief\, Legal Officer\, DexCom\, Inc.\nAneta Ferguson\, Senior Vice President and General Counsel\, Adverum Biotechnologies\nMichael Mueller\, General Counsel\, Sidewinder Therapeutics\, Inc.\n\nSidley Speakers \n\nTorey Cope\, Food\, Drug\, and Medical Device Regulatory\nMeenakshi Datta\, Healthcare: Drug and Medical Device Regulatory\nCarlton Fleming\, Capital Markets\nCindy Lovering\, Global Finance\nJames Lu\, Emerging Companies and Venture Capital\nJon Olsen\, M&A\, Emerging Companies and Venture Capital\nAdam Welland\, Technology and Life Sciences Transactions\nSharon Flanagan\, M&A\, Capital Markets\, Corporate Governance\n\nAgenda \n1:00 p.m.: Registration\n1:30 – 4:30 p.m.: \n\nClinical Research Challenges and Opportunities\nKey Considerations for Press Releases and SEC Disclosures\nFireside Chat: The Importance of Regulatory Strategy and Compliance from Seasoned Emerging Growth GCs\n\n4:30 – 6:30 p.m.: Cocktail Reception \nCLE credit for this program is pending.
URL:https://goodlifesci.sidley.com/event/regulatory-know-how-for-growth-stage-life-sciences-innovators/
LOCATION:Torrey Heights\, 11208 El Camino Real\, San Diego\, CA\, 92130\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250519
DTEND;VALUE=DATE:20250520
DTSTAMP:20260403T140829
CREATED:20250212T184003Z
LAST-MODIFIED:20250401T204125Z
UID:2163-1747612800-1747699199@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration\, new technologies\, the investment landscape\, and more. \n \n\n\nFor more information\, contact bosevents@sidley.com. \n\n\nThis year’s fifth annual event will be held in the stunning Institute of Contemporary Art/Boston lobby\, followed by a reception on the picturesque harbor front plaza. \nPlease see below for details on our newly announced panels and panelists. \nWHO SHOULD ATTEND\nExecutives\, Investors\, General Counsel\, and Company Counsel \nAGENDA\nRegistration: 1:30 p.m. ET\nProgram: 2:00 p.m. ET\nReception: 5:00 p.m. – 6:30 p.m. ET \nFEATURED PANEL TOPICS \nThe New Administration\, Trade Wars\, and GC Strategies For Managing A Changing Environment\nAs the New Administration brings personnel and policy changes to HHS and FDA\, and trade wars add new considerations for product development and manufacturing\, we reflect on key developments and strategies GCs use to successfully manage the opportunities and risks in a changing environment. \n– Lana Gladstein\, General Counsel\, Seaport Therapeutics \n– Jose Truzman\, General Counsel – U.S.\, Intercept Pharmaceuticals\, Inc. \n– Aaron Applebaum\, Counsel\, Global Arbitration\, Trade and Advocacy \n– Jackson Garvey\, Partner\, Restructuring & Liability Management \n– Becky Wood\, Partner\, Global Co-leader\, Food\, Drug and Medical Device and Former Chief Counsel\, FDA \nNew Product Development Pathways for Success\nThis panel will discuss key areas of focus during product development to set companies up for success\, including the use of artificial intelligence (AI)\, pre-approval compliance considerations\, and pricing strategies. \n– Meena Datta\, Partner\, Global Co-leader\, Healthcare\n– Deeona Gaskin\, Partner\, Food\, Drug and Medical Device and Former Associate Chief Counsel for Enforcement\, FDA \nNavigating Life Sciences Transactions in a Dynamic Economic Landscape\nThis panel will discuss the evolving landscape of life sciences transactions\, including emerging trends in the current investment climate. \n– Shaan Gandhi\, Head of Strategic Partnerships\, Pfizer Ignite \n– Paresh Kumar\, Vice President\, Biotech Private Equity\, Ally Bridge Group \n– Jason Tse\, Vice President Corporate Development\, McKesson \n– Chris York\, Vice President\, General Counsel & Chief of Staff\, Orchard Therapeutics \n– Mat Eapen\, Partner\, Investment Funds \nKEYNOTE ADDRESS\n“Get Your Mindset Right”: Thriving in Change\nA Conversation with Kirk Taylor\, MD on Navigating Changing Times \nKirk Taylor\, MD\nPresident & CEO\nMassachusetts Life Sciences Center \nKirk Taylor\, MD is a global pharmaceutical executive with expertise in Phase II – IV drug development\, including CNS\, oncology and rare disease. As Chief Medical Officer\, Chief Strategy Officer and SVP Medical Affairs\, he has restructured organizations\, created strategic operating plans\, and shaped corporate culture. His entrepreneurial acumen assisted in leading biotech start-up companies to successful IPOs and multiple funding rounds. He is people-first focused\, leading teams with respect and innovation. In recognition of his positive impact\, he was awarded the 2023 PharmaVoice 100 Executives Award. \nDr. Taylor received his Bachelor of Arts from Harvard College and studied piano at the Longy School of Music in Cambridge. He completed his Doctor of Medicine from the State University of New York\, Downstate\, his neurology residency at Einstein College of Medicine\, and a post-doc at UCSF.
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-4/
LOCATION:The Institute of Contemporary Art/Boston\, 25 Harbor Shore Drive\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250520T173000
DTEND;TZID=America/Chicago:20250520T200000
DTSTAMP:20260403T140829
CREATED:20250304T201351Z
LAST-MODIFIED:20250324T203422Z
UID:2183-1747762200-1747771200@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network Event – Brussels
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion on topical issues of pharmaceutical legislation and policy. \n \nRSVP here. \nSPEAKERS \n\nRainer Becker\, Director\, DG SANTE\, European Commission\nVictoria Kitcatt\, Vice President and Assistant General Counsel\, Head of EU/International Regulatory Law\, Pfizer\nLaetitia Szaller\, General Counsel\, Head of Compliance and ESG\, Egetis Therapeutics\n\nA Q&A session will follow the discussion. \nAGENDA \n5:30 p.m. – Welcome\n6:00 p.m. – Panel discussion\n7:00 p.m. – Networking reception and canapés \nAll are invited to attend WLSN events.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-event-brussels/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20250603T154500
DTEND;TZID=Europe/Zurich:20250603T170000
DTSTAMP:20260403T140829
CREATED:20250505T155312Z
LAST-MODIFIED:20250505T155329Z
UID:2252-1748965500-1748970000@goodlifesci.sidley.com
SUMMARY:Good Manufacturing Practice 2025AI in Manufacturing
DESCRIPTION:Join us for an insightful and practical webinar on “Navigating AI Adoption in GMP-Regulated Areas While Staying Compliant.” \n \nWebinar | RSVP here. \nKey Insights: \n\nAI in Pharma Production: Explore how AI is revolutionizing pharmaceutical production through process automation\, real-time quality control\, predictive maintenance\, and AI-driven batch release decisions.\nRegulatory Perspectives: Gain insights into how regulators in the U.S. and the EU are approaching AI in GMP-compliant manufacturing\, focusing on validation\, risk management\, and compliance expectations.\nBroader Frameworks: Understand how AI adoption fits into broader regulatory frameworks like the EU AI Act.\n\nFeatured Speakers: \n\nGert Thurau\, Lead Technology Innovation Manufacturing\, CMC Regulatory Policy\, Roche\nJames Johnson\, Partner\, Sidley\nDaniel J. Roberts\, Senior Director\, Regulatory Compliance\, Sidley\nEva von Mühlenen\, Senior Advisor\, Sidley\n\nWhy Attend? \nThis session will provide a real-world discussion on how companies can effectively integrate AI into their operations while adhering to Good Manufacturing Practice (GMP) regulations. \nLearn from industry and regulatory thought leaders about the latest trends and best practices in AI adoption within GMP-regulated environments. \nWho Should Attend? \nExecutives\, in-house counsel\, quality and compliance managers and officers interested in and/or facing GMP compliance and quality management challenges in Switzerland. \n\nFor more information or questions\, please contact gvaevents@sidley.com. \nNothing in this program may be quoted or used in any manner without the express written consent of Sidley Austin LLP. The views expressed in this program are the views of the participants\, and not necessarily those of the firm. This program is for informational purposes only and should not be considered legal advice or creating an attorney-client relationship.
URL:https://goodlifesci.sidley.com/event/good-manufacturing-practice-2025ai-in-manufacturing/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250723T130000
DTEND;TZID=America/Chicago:20250723T163000
DTSTAMP:20260403T140829
CREATED:20250611T160543Z
LAST-MODIFIED:20250625T215158Z
UID:2345-1753275600-1753288200@goodlifesci.sidley.com
SUMMARY:Bay Area Lifesciences Roundtable Navigating Uncertainty and Charting a New Course
DESCRIPTION:Join industry leaders\, investors\, and seasoned regulatory counsel for an exclusive event focused on thriving during times of change in the life sciences sector. Through dynamic panel discussions\, we’ll explore the latest trends in regulation\, financing\, market dynamics\, and federal health policy\, all with a focus on how companies can continue to realize the transformative impact of new therapies and technologies. Don’t miss this opportunity to connect\, learn\, and chart a new course for long-term business success. \nRSVP here. \nAGENDA\nRegistration | 1:00 p.m.\nProgram | 1:30 p.m.\nReception 4:30 p.m. \nWho may be interested in attending: Executives\, Directors\, Investors\, and In-House Counsel \nFEATURED PANELS \nRegulatory Realities – Proactive Strategies in a Shifting Landscape \nExplore how companies are developing new strategies to respond to the latest developments at HHS\, FDA\, and CMS\, including major shifts in FDA leadership\, staffing\, and policy priorities\, potential impacts on regulatory timelines and new product approvals\, and new proposals related to drug pricing and reimbursement. Hear from industry insiders on how to engage effectively with regulators and adapt to new expectations in an era of uncertainty. \nSPEAKERS\n \n\nAnthony Davies\, Ph.D.\, Founder & CEO\, Dark Horse Consulting\nHae-Won Min Liao\, Vice President\, U.S. Legal Business Partner\, Gilead Sciences\nEmily Marden\, Senior Counsel\, Sidley\nCatherine Starks\, Partner\, Sidley\n\nAdditional panelists to be announced \nFinancing the Future – Paths to Growth and Liquidity \nDiscover how investment opportunities are evolving\, with a focus on financing and liquidity options including debt\, royalty financing\, mergers\, and other strategic transactions. Leading advisors and investors will share their experience\, including how shifting geopolitical and regulatory factors are shaping deals\, and what it takes to secure funding and achieve liquidity in today’s market. \nSPEAKERS\n \n\nRyuk Byun\, Managing Director\, Morgan Stanley\nHutch Corbett\, Managing Partner\, Armentum Partners\nCarlton Fleming\, Partner\, Sidley\nFrank Rahmani\, Partner\, Sidley\n\nAdditional panelists to be announced \nThe GLP-1 Effect – Disruption\, Demand\, and What’s Next for Biotech \n Using GLP-1 as a case study\, dive into the latest trends in product development\, pricing and reimbursement\, market dynamics\, and federal health policy. This panel will examine issues that have arisen for the paradigm-shifting GLP-1/GIP/Gcg product category\, to reveal for the future of innovation across the entire life sciences industry. \nSPEAKERS \n\nScott Akamine\, Chief Legal Officer\, Kailera Therapeutics\nMichael Hulka\, Senior Vice President and Deputy General Counsel\, Eli Lilly and Company\nTorrey Cope\, Partner\, Sidley\n\nAdditional panelists to be announced \nCLE credit for this program is pending.\n\nFor more information\, contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/bay-area-lifesciences-roundtable-navigating-uncertainty-and-charting-a-new-course/
LOCATION:SFMOMA\, 147 Minna St. Floor 5\, San Francisco\, CA\, 94103\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20250902T140000
DTEND;TZID=Europe/Zurich:20250902T183000
DTSTAMP:20260403T140829
CREATED:20250425T150936Z
LAST-MODIFIED:20250429T155305Z
UID:2246-1756821600-1756837800@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2025Staying Competitive in a Shifting Regulatory Landscape
DESCRIPTION:The Swiss MedTech industry stands at a critical crossroads: navigating rapid regulatory evolution\, geopolitical shifts\, and emerging technologies. \n \n\n\nRSVP here. \nFor more information\, please contact Geneva Events. \n\n\nJoin us in Bern for an interactive afternoon featuring regulators\, industry leaders\, legal professionals\, and scientific advisors who will share practical insights\, best practices\, and strategic foresight. \nKey highlights on the agenda include: \n\nRegulatory Realities and Priorities\nHow Swiss MedTech Stays Competitive Amid Regulatory Shifts\nGlobal Trade and Politics\nU.S. Policy in 2025 – Implications for Swiss Market Access and Trade Strategy\nCorporate Responsibility\nFrom ESG to the Omnibus Act – What Swiss MedTech Must Now Comply With\nNew Pathway of Regulating Artificial Intelligence in Switzerland\nCompetitive Edge or Compliance Hurdle?
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2025staying-competitive-in-a-shifting-regulatory-landscape/
LOCATION:Casino Bern\, Casinoplatz 1\, 3011\, Bern\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Asia/Singapore:20250903T093000
DTEND;TZID=Asia/Singapore:20250903T130000
DTSTAMP:20260403T140829
CREATED:20250828T181249Z
LAST-MODIFIED:20250828T181450Z
UID:2427-1756891800-1756904400@goodlifesci.sidley.com
SUMMARY:Singapore Life Sciences Roundtable
DESCRIPTION:This intimate\, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical\, medtech\, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific. \n \n\n\nRSVP here. \n\n\nTopics include: \n– The New DOJ White Collar Enforcement Playbook\nWhat it means for APAC operations and compliance functions \n– The New U.S. Administration and the FDA\nTaking stock of paradigm-shifting developments in drug and device regulation \n– Life Sciences Transactions in APAC\nNavigating deal risks\, regulatory scrutiny\, and cross-border trends \nPROGRAM\nRegistration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT\nSidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT\nNetworking Lunch: 12:00 p.m. – 1:00 p.m. SGT \nFor questions or more information\, please contact asiaevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/2427/
LOCATION:Sidley\, 1501 K Street\, NW Washington\, D.C.\, 20005\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250915T180000
DTEND;TZID=America/Chicago:20250915T200000
DTSTAMP:20260403T140829
CREATED:20250812T223817Z
LAST-MODIFIED:20250812T223841Z
UID:2392-1757959200-1757966400@goodlifesci.sidley.com
SUMMARY:Sidley’s Medicaid Drug Rebate Program Summit Cocktail Reception
DESCRIPTION:Please join members of Sidley’s Drug Pricing Team for appetizers and cocktails – right near Chicago’s iconic Bean in Millennium Park – following Day 1 of the MDRP Summit. \n \n\n\nRSVP here \n\n\nWe look forward to connecting with you! \nFor questions\, please contact chevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/2392/
LOCATION:Avli on the Park\, 180 N Field Blvd\, Chicago\, IL\, 60601
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250930
DTEND;VALUE=DATE:20251001
DTSTAMP:20260403T140829
CREATED:20250218T171058Z
LAST-MODIFIED:20250218T205917Z
UID:2169-1759190400-1759276799@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2025
DESCRIPTION:With deal and investment activity remaining critical to the success of the life sciences and healthcare industry\, Sidley is bringing together senior pharma\, biotech\, healthcare\, private equity\, and venture capital leads to provide their insights on key topics\, trends\, and opportunities. \n \n\n\nRSVP here. \n\n\nJoin Sidley and industry leaders from across the globe for this in-person\, one-day event in London\, with the option to stream and network virtually from outside the UK. \nWe look forward to incisive content\, robust discussion\, and valuable networking during a day of looking at the continued combination of innovation and capital driving positive patient outcomes and investment returns. \nView the Sidley Healthcare Investment Conference 2024 highlights. 
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-conference-2025/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20251021T173000
DTEND;TZID=Europe/Zurich:20251021T210000
DTSTAMP:20260403T140829
CREATED:20250630T164241Z
LAST-MODIFIED:20250630T164357Z
UID:2357-1761067800-1761080400@goodlifesci.sidley.com
SUMMARY:Women's Life Sciences NetworkGeopolitical and Trade Uncertainties: Strategies for the Life Sciences Industry
DESCRIPTION:Join us in Basel for our next Women’s Life Sciences Network event\, which will feature a panel discussion with leading life science industry representatives about the challenges and opportunities arising from increasingly volatile and fragmented international trade dynamics. \n \n\n\nRSVP here. \nThe panel will share insights and considerations on the impact on life science companies’ operations and compliance efforts of\, among others\, new tariffs\, retaliation measures\, and other recent trade restrictions implemented in an evolving geopolitical context where countries seek to rebalance trade relations. A Q&A session will follow the moderated discussion. \n\n\nAll are invited to attend WLSN events. \nAGENDA \n5:30 p.m. – Arrival and registration\n6:00 p.m. – Panel discussion and Q&A\n7:30 p.m. – Networking and apéro riche \nFor more information\, please contact brevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-networkgeopolitical-and-trade-uncertainties-strategies-for-the-life-sciences-industry/
LOCATION:Memox\, Peter-Merian Strasse 80\, Basel\, 4052\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260112T113000
DTEND;TZID=America/Los_Angeles:20260112T143000
DTSTAMP:20260403T140829
CREATED:20251106T172447Z
LAST-MODIFIED:20251113T221810Z
UID:2566-1768217400-1768228200@goodlifesci.sidley.com
SUMMARY:Biotech Dealmaking - Regulatory Considerations for the Next Wave of Development-Stage Transactions - Program and Lunch
DESCRIPTION:Join members of Sidley’s Global Life Sciences team for a lunchtime CLE-accredited program during the JPM Healthcare Conference discussing the latest regulatory trends impacting the next wave of development-stage transactions.\n \nLed by Meena Datta\, global co-leader of Sidley’s Healthcare practice; Torrey Cope\, partner in Sidley’s Food Drug and Medical Device (FDMD) practice; and Sally Wagner Partin\, partner in Sidley’s M&A practice\, this session provides keen insights on the considerations driving recent biotech dealmaking. 1 hour CLE credit available. \nFor questions\, please contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/biotech-dealmaking-regulatory-considerations-for-the-next-wave-of-development-stage-transactions-program-and-lunch/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260112T133000
DTEND;TZID=America/Los_Angeles:20260112T173000
DTSTAMP:20260403T140829
CREATED:20251120T220607Z
LAST-MODIFIED:20251211T230935Z
UID:2582-1768224600-1768239000@goodlifesci.sidley.com
SUMMARY:Connecting Clusters of Excellence: Europe as Your Gateway to Global Success
DESCRIPTION:Join Sidley\, Biovia\, Health Campus Limburg DC\, and others for an engaging afternoon exploring collaborative growth opportunities across the global life sciences landscape. \n \nRSVP here. \nThe event will feature two dynamic panel discussions\, with the latter being moderated by Sidley’s Becky Wood\, global co-leader of Sidley’s FDA practice and former Chief Counsel at FDA. \nPanel 1: Europe Recharged: Innovation Thrives Here. We Are Ready for the Global Stage. \nEurope’s biotech and healthtech ecosystems are accelerating. With strong public-private partnerships\, world-class research\, and coordinated investment strategies\, Europe is no longer catching up\, it’s setting the pace. Discover how clusters across the continent are shaping global markets through collaboration and scale. \nPanel 2: Redefining Women’s Health: Europe and the U.S. Unite to Power Innovation\, Investment\, and Impact. \nA new wave of investors and innovators is turning women’s health into one of the fastest-growing markets in healthcare. How can we ensure women’s health is not just a “hot topic\,” but an enduring pillar of innovation and research? This panel brings together U.S. and European leaders driving science\, technology\, and capital toward an overdue revolution in women’s health\, from overlooked needs to global opportunities. \nThis gathering brings together leaders\, innovators\, and ecosystem builders to spark meaningful dialogue and foster new pathways for international collaboration. \nPlease note that delegate contact details may be passed between Sidley Austin LLP\, Biovia\, and Health Campus Limburg DC for the purposes of organizing and administering these events\, and for contacting you about these events. The organizers are using third party websites\, not controlled by Sidley\, and your personal information will be processed in accordance with the Eventbrite Privacy Policy. For information on Sidley’s use of your personal information please refer to our Privacy Policy and for questions about these events please contact sfevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/connecting-clusters-of-excellence-europe-as-your-gateway-to-global-success/
LOCATION:The Town Hall\, 555 California Street\, San Francisco\, CA\, 94104\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260128T093000
DTEND;TZID=America/New_York:20260128T163000
DTSTAMP:20260403T140829
CREATED:20251001T204927Z
LAST-MODIFIED:20251203T215202Z
UID:2547-1769592600-1769617800@goodlifesci.sidley.com
SUMMARY:At the Table: Serving Up a Lively Discussion With the FDA and USDA
DESCRIPTION:Please join Sidley’s Food\, Drug\, and Medical Device team for a Meet the Regulators Roundtable which will include: Stephen A. Vaden\, USDA Deputy Secretary; Tyler Clarkson\, USDA General Counsel; Kyle Diamantas\, FDA Deputy Commissioner for Human Foods\, and Sean Keveney\, FDA Chief Counsel. \n \n\n\n\n\nFor registration information\, please contact dcevents@sidley.com. \n\n\n\n\nAgenda \nRegistration | 9:30 a.m. ET\nPanels | 10:00 a.m. – 12:10 p.m. ET\nLunch | 12:15 p.m. – 1:15 p.m. ET\nMeet the Regulators Roundtable | 1:30 p.m. – 3:00 p.m. ET\nCocktail Reception | 3:00 p.m. – 4:30 p.m. ET \nThe event will bring together industry leaders for a lively discussion on regulatory compliance\, enforcement actions\, litigation\, and related issues facing the food industry. \nPanel discussions prior to the Regulator Roundtable will include: \n– The Changing Landscape in Washington Food Regulation\n– Enforcement and Litigation – Risks\, Opportunities\, and Trends \nCLE credit is pending for this program. Sidley Austin LLP is an Approved Accredited Provider of CA\, IL\, and NY CLE credit.
URL:https://goodlifesci.sidley.com/event/at-the-table-serving-up-a-lively-discussion-with-the-fda-and-usda/
LOCATION:Sidley\, 1501 K Street\, NW Washington\, D.C.\, 20005\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260212T083000
DTEND;TZID=Europe/Brussels:20260212T170000
DTSTAMP:20260403T140829
CREATED:20251202T213607Z
LAST-MODIFIED:20251202T213607Z
UID:2591-1770885000-1770915600@goodlifesci.sidley.com
SUMMARY:Life Sciences College 2026
DESCRIPTION:Join EUCOPE and Sidley for the annual Life Sciences College (LSC) for an exclusive\, full-day forum on the future of life sciences in Europe. \n \nRSVP here. \nGet ready for a high-impact day of insight and connection at LSC\, where life sciences leaders gather to explore the legal\, regulatory\, and policy shifts shaping the industry. \nWhy Attend?\n \n– Connect with key decision-makers from the European Commission\, regulatory bodies\, industry\, and the investment community \n– Hear exclusive insights on legal\, policy\, and regulatory trends shaping the EU life sciences landscape \n– Join strategic discussions on emerging challenges and opportunities across the sector \n– Network with leaders from pharma\, biotech\, medtech\, and venture capital \nWho Should Attend \nIn-house counsel\, regulators\, and regulatory personnel.There is no registration fee to attend this event. \nFor more information\, contact brevents@sidley.com.
URL:https://goodlifesci.sidley.com/event/life-sciences-college-2026/
LOCATION:Renaissance Brussels Hotel\, Rue du Parnasse 19\, Brussels\, 1000\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260519
DTEND;VALUE=DATE:20260522
DTSTAMP:20260403T140829
CREATED:20260223T171206Z
LAST-MODIFIED:20260223T171206Z
UID:2648-1779148800-1779407999@goodlifesci.sidley.com
SUMMARY:Sidley Sponsors the 2026 EU Pharma Law Forum
DESCRIPTION:Sidley is proud to sponsor and participate in the EU Pharma Law Forum\, the leading annual gathering of regulators\, in-house counsel\, policymakers\, and industry stakeholders shaping the future of European pharmaceutical law. \nView agenda here. \nSidley partner Anne Robert will be speaking on “How to Respond to Dawn Raids and Investigations.” Josefine Sommer will present on “Early Experiences from the HTA Regulation: Market Access Pricing and Reimbursement.” \nWe look forward to connecting with clients\, colleagues\, and industry leaders in Brussels to discuss the evolving legal landscape and the strategic considerations facing the pharmaceutical sector in 2026 and beyond.
URL:https://goodlifesci.sidley.com/event/sidley-sponsors-the-2026-eu-pharma-law-forum/
LOCATION:Steigenberger Icon Wiltcher’s\, Brussels
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260519T173000
DTEND;TZID=Europe/Brussels:20260519T210000
DTSTAMP:20260403T140829
CREATED:20260306T193120Z
LAST-MODIFIED:20260324T183824Z
UID:2654-1779211800-1779224400@goodlifesci.sidley.com
SUMMARY:Women’s Life Sciences Network – Biotech Act: Funding and Investment Opportunities
DESCRIPTION:Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. \n \n\n\n\nRSVP here. \n\n\n\nOur speakers will discuss the proposed Biotech Act I\, focusing on funding and regulatory support opportunities for the European biopharmaceutical industry. \nJoin our moderated panel discussion with: \nFelicitas Riedl\, Director of Innovation and Competitiveness Department\, European Investment Bank\nAlexandra Eftimie\, Legal and Policy Officer\, European Commission\nKristin Thompson\, Director\, Merieux Equity Partner\nValerie Vanhooren\, CEO & Co-founder\, Ona Therapeutics \nThe event will include a video address by Stine Bosse\, MEP for the Renew Europe group and Vice Chair of the Committee on Public Health in the European Parliament. \nAgenda \nWelcome and registration – 5:30 p.m. CEST\nPanel discussion and Q&A – 6:00 p.m. CEST\nNetworking reception and canapés – 7:30 p.m. CEST \nStay tuned for more details. All are invited to attend WLSN events.
URL:https://goodlifesci.sidley.com/event/womens-life-sciences-network-biotech-act-funding-and-investment-opportunities/
LOCATION:Comet\, Place Stephanie 50\, Brussels\, 1050\, Belgium
END:VEVENT
END:VCALENDAR